NCT03839979 is a clinical trial of BIOLINE HCV kits in Hepatitis C, Acute, sponsored by Cairo University.

Who is sponsoring NCT03839979?

NCT03839979 is sponsored by Cairo University.

What drugs are being tested in NCT03839979?

Interventions in NCT03839979: BIOLINE HCV kits, ACCU-CHEK kits, ErKameter 3000 mercury manometer.

What condition does NCT03839979 study?

NCT03839979 studies Hepatitis C, Acute, Diabetes, Hypertension.

Is NCT03839979 still recruiting?

NCT03839979 is currently completed. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT03839979

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt

Completed Last updated 18 March 2021

What this trial tests

trial testing BIOLINE HCV kits in Hepatitis C, Acute in 71,975 participants. Completed in 31 January 2019.

Timeline

1 October 2018

Primary endpoint
31 December 2018

31 January 2019

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	71,975
Start date	1 October 2018
Primary completion	31 December 2018
Estimated completion	31 January 2019
Sites	1 location across Egypt

Drugs / interventions tested

BIOLINE HCV kits
ACCU-CHEK kits
ErKameter 3000 mercury manometer

Conditions studied

Hepatitis C, Acute — all drugs for Hepatitis C, Acute →
Diabetes — all drugs for Diabetes →
Hypertension — all drugs for Hypertension →

Sponsor

Cairo University

Who can join

Adults 18 to 80, any sex, with Hepatitis C, Acute or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An observational double-blind cohort study that examined the association between HCV viral hepatitis, blood sugar level and systolic blood pressure in the Egyptian population

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03839979 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03839979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing